peripheral-nerve-stimulation
(3)
Maria Bennett Kept One Graduate-School Idea Alive for 28 Years. Then Came a $650 Million Exit.
A wheelchair project, a thesis, two acquired companies and one stubbornly durable question shaped Maria Bennett's route from an Indiana marching band to a Cleveland medtech exit.
The 60-Day Nerve Stimulator That Turned a Cleveland Thesis Into a $650 Million Exit
Maria Bennett noticed that an experiment built to restore movement was doing something patients valued more: easing pain. SPR spent the next 16 years turning that side effect into a temporary implant, a reimbursement machine, and a $650 million Medtronic acquisition.
NeuroBionics
NeuroBionics is a Boston-area neurotechnology company spun out of more than a decade of MIT research. It builds hair-thin, flexible bioelectronic fibers that reach neural targets through the body's blood vessels instead of open surgery. Its lead device, evStim, aims to deliver deep brain and peripheral nerve stimulation endovascularly, potentially widening access to neuromodulation therapy for conditions like Parkinson's disease, epilepsy, chronic pain, and depression.